BMS Sees Zeposia As Safer Oral Option In Ulcerative Colitis

Efficacy Comparable To Gilead/Galapagos JAK Inhibitor Filgotinib

 
• By Mandy Jackson
  
Medical Concept: Ulcerative Colitis on Black Chalkboard. Medical Concept: Ulcerative Colitis - Black Chalkboard with Hand Drawn Text and Red Stethoscope. Top View. 3D Rendering.
Zeposia could be the first S1P receptor modulator approved for UC • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D